-
Blood Borne VirusesHepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
-
Enteric Viruses and BacteriaClostridium difficile EHEC Norovirus Rotavirus
-
Human Adenovirus, Human Herpesvirus and PolyomavirusHuman adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
-
Respiratory Viruses, Bacteria and FungiHuman adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
-
Tropical and other Viruses, Bacteria and ParasitesAHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
Gastrointestinal EQA Programme
-
Adenovirus DNA
-
Bacterial Gastroenteritis
-
Clostridium difficile DNA
-
Diarrheagenic Escherichia coli
-
Helicobacter pylori
-
Norovirus RNA
-
Parasitic Gastroenteritis
-
Viral Gastroenteritis
In recent years molecular diagnostic techniques such as real-time PCR have also been introduced for the laboratory diagnosis of gastroenteritis, including the ability to simultaneously screen for a wide range of enteric pathogens using multiplex assays. As a result, molecular diagnostic techniques are increasingly being used in the routine laboratory setting for detection, determination and surveillance of a wide range of enteric pathogens. The general aim of this group of EQA schemes is to allow laboratories to assess their ability in the use of molecular diagnostic tests for a range of viral, bacterial and parasitic enteric pathogens.